| Recruiting | Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide NCT07429864 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Endoscopic Ultrasound Shear Wave Elastography Study NCT06592820 | Olympus Corporation of the Americas | — |
| Recruiting | Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients NCT06814600 | Centre Hospitalier Universitaire Saint Pierre | — |
| Not Yet Recruiting | HIBOC = Hepatic Imaging Biomarkers in Obese Children NCT06463223 | Sahlgrenska University Hospital | — |
| Recruiting | Screening for Chronic Liver Diseases in General Population NCT06366425 | University Hospital, Montpellier | N/A |
| Recruiting | Stem Cell Applications in Biliary Atresia Patients NCT06564740 | Necmi Kadıoğlu Hospital | N/A |
| Enrolling By Invitation | Reducing Non-Alcoholic Steatohepatitis NCT06519448 | Military University Hospital, Prague | N/A |
| Recruiting | COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER NCT05692024 | Massachusetts General Hospital | Phase 1 / Phase 2 |
| Recruiting | Find HDV and Determine Its Status in Turkey NCT06248580 | Yaşar Bayındır, MD | — |
| Recruiting | Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis. NCT06293378 | The Second Affiliated Hospital of Chongqing Medical University | N/A |
| Recruiting | Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial NCT06102980 | Instituto Ecuatoriano de Enfermedades Digestivas | N/A |
| Unknown | Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM NCT06005012 | University of California, San Diego | Phase 2 |
| Recruiting | Global Research Initiative for Patients Screening on MASH NCT05651724 | Julius Clinical | — |
| Recruiting | The Liver Care Trial NCT05855031 | Zealand University Hospital | N/A |
| Unknown | Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification NCT06111859 | King's College Hospital NHS Trust | N/A |
| Unknown | Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection NCT05567614 | Assiut University | — |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis NCT05402371 | Hepion Pharmaceuticals, Inc. | Phase 2 |
| Unknown | Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH NCT05120557 | E-Scopics | N/A |
| Unknown | Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records. NCT05218538 | HaEmek Medical Center, Israel | — |
| Active Not Recruiting | Liver Cancer Prevention Randomized Control Trial NCT05196867 | M.D. Anderson Cancer Center | N/A |
| Active Not Recruiting | Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients NCT05147090 | The University of Hong Kong | Phase 4 |
| Completed | Volatile Organic Compounds for the Assessment of Liver Disease NCT04620538 | Imperial College London | — |
| Active Not Recruiting | Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes NCT04595474 | Joslin Diabetes Center | — |
| Terminated | Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis NCT04175392 | Corewell Health East | Phase 1 / Phase 2 |
| Unknown | Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Di NCT05473806 | Seung Up Kim | Phase 4 |
| Unknown | Liver Fibrosis and Gut Microbiota in Patients With Psoriasis Vulgaris and Rheumatoid Arthritis on Methotrexate NCT04493762 | The University of Hong Kong | — |
| Completed | A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects NCT04480710 | Hepion Pharmaceuticals, Inc. | Phase 2 |
| Active Not Recruiting | LITMUS Imaging Study NCT05479721 | University of Oxford | — |
| Active Not Recruiting | DIAbetes and NAFLD NCT06315361 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Completed | Evaluation of Liver Fibrosis With 2D-Shear Wave Elastography NCT04759521 | Seyhmus Kavak | — |
| Completed | An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis NCT03656068 | Pinnacle Clinical Research, PLLC | Phase 2 |
| Completed | Shear Wave Elastography NCT04493346 | Baylor Research Institute | — |
| Unknown | Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity NCT03492879 | Prof. Ziv Ben-Ari MD | N/A |
| Unknown | Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic NCT03222167 | Institute Of Cardiology & Internal Diseases, Kazakhstan | Phase 3 |
| Active Not Recruiting | Chronic Hepatitis B Virus Infection in Zambia NCT03158818 | University of Alabama at Birmingham | — |
| Completed | Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR NCT03659058 | Zagazig University | N/A |
| Unknown | Comparison of Smart-Shear Wave Elastography and Transient Elastography NCT02569567 | Asan Medical Center | — |
| Active Not Recruiting | Liver Fibrosis in Zambian HIV-HBV Co-infected Patients NCT02344680 | University of Alabama at Birmingham | — |
| Recruiting | The European NAFLD Registry NCT04442334 | Newcastle University | — |
| Completed | The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and Histo NCT04380493 | Hospital Vall d'Hebron | — |
| Completed | Diffusion-weighted Imaging Magnetic Resonance for Assessing Liver Fibrosis NCT02682108 | Mahidol University | N/A |
| Completed | Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric Sur NCT03548597 | European Georges Pompidou Hospital | — |
| Completed | Impact of Chlordecone on Active Chronic Hepatitis NCT03373396 | Centre Hospitalier Universitaire de la Guadeloupe | N/A |
| Completed | Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment NCT00006164 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |